{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T01:56:24Z","timestamp":1781315784355,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Spinal muscular atrophy (SMA) is a paediatric neuromuscular disease caused by alterations of the survival motor neuron (<jats:italic>SMN<\/jats:italic>) gene, which results in progressive degeneration of motor neurons (MNs). Although effective treatments for SMA patients has been recently developed, the molecular pathway involved in selective MNs degeneration has not been yet elucidated. Disruption of axonal transport is a common feature of motor neuron diseases (MNDs); specifically, mutations at the C-terminal of the kinesin KIF5A, have been linked to neurodegenerative disorders involving MNs degeneration such as amyotrophic lateral sclerosis (ALS). Therefore, the present study attempts to investigate potential alterations of the axonal transport complex that includes KIF5A in a SMA mouse model. We demonstrated that KIF5A is downregulated in the spinal cord of SMA mice both in early and late phases of the disease. A miRNA-based strategy was developed in the attempt to prevent KIF5A downregulation, thus restoring its physiological levels. Indeed, we demonstrated that miR-140-3p was up-regulated in the spinal cord of SMA mice during disease progression and was able to negatively modulate KIF5A expression. Furthermore, the intracerebroventricular injection of an antagomir molecule, able to block miR140-3p function, resulted in a reduction of SMA severity in terms of improved behavioural performance. Based on these results, we indicated KIF5A as a distinctive mechanism of MNDs progression and suggested that developing a strategy able to prevent KIF5A downregulation could be beneficial, not only in SMA but also in other neurodegenerative diseases.<\/jats:p>","DOI":"10.1038\/s41420-025-02663-x","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:24:25Z","timestamp":1759843465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MiR-140-3p regulates axonal motor protein KIF5A and contributes to axonal transport degeneration in SMA"],"prefix":"10.1038","volume":"11","author":[{"given":"Markella","family":"Baklou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-8495","authenticated-orcid":false,"given":"Valeria","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Laudati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xhesika","family":"Kolici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Brancaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia","family":"De Iesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenella","family":"Anzilotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"2663_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, et al. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis. 2017;12:124.","journal-title":"Orphanet J Rare Dis"},{"key":"2663_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155\u2013165.","journal-title":"Cell"},{"key":"2663_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet. 1999;8:1177\u201383.","journal-title":"Hum Mol Genet"},{"key":"2663_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","volume":"51","author":"WD Arnold","year":"2015","unstructured":"Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015;51:157\u2013167.","journal-title":"Muscle Nerve"},{"key":"2663_CR5","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/hmg\/ddy195","volume":"27","author":"EJN Groen","year":"2018","unstructured":"Groen EJN, Perenthaler E, Courtney NL, Jordan CY, Shorrock HK, van der Hoorn D, et al. Temporal and tissue-specific variability of SMN protein levels in mouse models of spinal muscular atrophy. Hum Mol Genet. 2018;27:2851\u201362.","journal-title":"Hum Mol Genet"},{"key":"2663_CR6","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1007\/s00018-018-2849-1","volume":"75","author":"H Chaytow","year":"2018","unstructured":"Chaytow H, Huang YT, Gillingwater TH, Faller KME. The role of survival motor neuron protein (SMN) in protein homeostasis. Cell Mol Life Sci. 2018;75:3877\u201394.","journal-title":"Cell Mol Life Sci"},{"key":"2663_CR7","first-page":"519","volume":"25","author":"RN Singh","year":"2020","unstructured":"Singh RN, Seo J, Singh NN. RNA in spinal muscular atrophy: therapeutic implications of targeting. Expert Opin Ther Targets. 2020;25:519\u201336.","journal-title":"Expert Opin Ther Targets"},{"key":"2663_CR8","doi-asserted-by":"publisher","first-page":"7S3","DOI":"10.1016\/S0929-693X(20)30269-4","volume":"27","author":"S Lefebvre","year":"2020","unstructured":"Lefebvre S, Sarret C. Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA). Arch Pediatr. 2020;27:7S3\u20137S8.","journal-title":"Arch Pediatr"},{"key":"2663_CR9","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1242\/dmm.030148","volume":"10","author":"M Bowerman","year":"2017","unstructured":"Bowerman M, Becker CG, Y\u00e1\u00f1ez-Mu\u00f1oz RJ, Ning K, Wood MJA, Gillingwater TH, et al. Therapeutic strategies for spinal muscular atrophy: SMN and beyond. Dis Model Mech. 2017;10:943\u201354.","journal-title":"Dis Model Mech"},{"key":"2663_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn1624","volume":"6","author":"N Hirokawa","year":"2005","unstructured":"Hirokawa N, Takemura R. Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci. 2005;6:201\u201314.","journal-title":"Nat Rev Neurosci"},{"key":"2663_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1152\/physrev.00023.2007","volume":"88","author":"N Hirokawa","year":"2008","unstructured":"Hirokawa N, Noda Y. Intracellular transport and kinesin superfamily proteins, KIFs: structure, function, and dynamics. Physiol Rev. 2008;88:1089\u2013118.","journal-title":"Physiol Rev"},{"key":"2663_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000339529","volume":"12","author":"M Ku\u017ama-Kozakiewicz","year":"2013","unstructured":"Ku\u017ama-Kozakiewicz M, Chudy A, Gajewska B, Dziewulska D, Usarek E, Bara\u0144czyk-Ku\u017ama A. Kinesin expression in the central nervous system of humans and transgenic hSOD1G93A mice with amyotrophic lateral sclerosis. Neurodegener Dis. 2013;12:71\u201380.","journal-title":"Neurodegener Dis"},{"key":"2663_CR13","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1523\/JNEUROSCI.20-17-06374.2000","volume":"20","author":"Y Kanai","year":"2000","unstructured":"Kanai Y, Okada Y, Tanaka Y, Harada A, Terada S, Hirokawa N. KIF5C, a novel neuronal kinesin enriched in motor neurons. J Neurosci. 2000;20:6374\u201384.","journal-title":"J Neurosci"},{"key":"2663_CR14","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1086\/344210","volume":"71","author":"E Reid","year":"2002","unstructured":"Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet. 2002;71:1189\u201394.","journal-title":"Am J Hum Genet"},{"key":"2663_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1399-0004.2011.01717.x","volume":"82","author":"C Crimella","year":"2012","unstructured":"Crimella C, Baschirotto C, Arnoldi A, Tonelli A, Tenderini E, Airoldi G, et al. Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet. 2012;82:157\u201364.","journal-title":"Clin Genet"},{"key":"2663_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jcm8010017","volume":"8","author":"M Filosto","year":"2018","unstructured":"Filosto M, Piccinelli SC, Palmieri I, Necchini N, Valente M, Zanella I, et al. A Novel Mutation in the Stalk Domain of KIF5A Causes a Slowly Progressive Atypical Motor Syndrome. J Clin Med. 2018;8:17.","journal-title":"J Clin Med"},{"key":"2663_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/cge.12831","volume":"91","author":"M Rydzanicz","year":"2017","unstructured":"Rydzanicz M, Jag\u0142a M, Kosinska J, Tomasik T, Sobczak A, Pollak A, et al. KIF5A de novo mutation associated with myoclonic seizures and neonatal onset progressive leukoencephalopathy. Clin Genet. 2017;91:769\u201373.","journal-title":"Clin Genet"},{"key":"2663_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ana.24744","volume":"80","author":"J Duis","year":"2016","unstructured":"Duis J, Dean S, Applegate C, Harper A, Xiao R, He W, et al. KIF5A mutations cause an infantile onset phenotype including severe myoclonus with evidence of mitochondrial dysfunction. Ann Neurol. 2016;80:633\u20137.","journal-title":"Ann Neurol"},{"key":"2663_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1083\/jcb.200301026","volume":"161","author":"CH Xia","year":"2003","unstructured":"Xia CH, Roberts EA, Her LS, Liu X, Williams DS, Cleveland DW, et al. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J Cell Biol. 2003;161:55\u201366.","journal-title":"J Cell Biol"},{"key":"2663_CR20","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202005051","volume":"220","author":"Y Fukuda","year":"2021","unstructured":"Fukuda Y, Pazyra-Murphy MF, Silagi ES, Tasdemir-Yilmaz OE, Li Y, Rose L, et al. Binding and transport of SFPQ-RNA granules by KIF5A\/KLC1 motors promotes axon survival. J Cell Biol. 2021;220:e202005051.","journal-title":"J Cell Biol"},{"key":"2663_CR21","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1242\/jcs.196287","volume":"129","author":"J Pu","year":"2016","unstructured":"Pu J, Guardia CM, Keren-Kaplan T, Bonifacino JS. Mechanisms and functions of lysosome positioning. J Cell Sci. 2016;129:4329\u201339.","journal-title":"J Cell Sci"},{"key":"2663_CR22","doi-asserted-by":"publisher","first-page":"106759","DOI":"10.1016\/j.nbd.2024.106759","volume":"204","author":"I Guerra San Juan","year":"2025","unstructured":"Guerra San Juan I, Brunner JW, Eggan K, Toonen RF, Verhage M. KIF5A regulates axonal repair and time-dependend axonal transport of SFPQ granules and mitochondria in human motor neurons. Neurobiol Dis. 2025;204:106759\u201373.","journal-title":"Neurobiol Dis"},{"key":"2663_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.neuron.2009.01.030","volume":"61","author":"AF Macaskill","year":"2009","unstructured":"Macaskill AF, Rinholm JE, Twelvetrees AE, Arancibia-Carcamo IL, Muir J, Fransson A, et al. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron. 2009;61:541\u201355.","journal-title":"Neuron"},{"key":"2663_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1083\/jcb.200601067","volume":"173","author":"EE Glater","year":"2006","unstructured":"Glater EE, Megeath LJ, Stowers RS, Schwarz TL. Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J Cell Biol. 2006;173:545\u201357.","journal-title":"J Cell Biol"},{"key":"2663_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nbd.2017.02.004","volume":"105","author":"KJ De Vos","year":"2017","unstructured":"De Vos KJ, Hafezparast M. Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?. Neurobiol Dis. 2017;105:283\u201399.","journal-title":"Neurobiol Dis"},{"key":"2663_CR26","doi-asserted-by":"publisher","first-page":"12776","DOI":"10.1523\/JNEUROSCI.3463-09.2009","volume":"29","author":"GA Morfini","year":"2009","unstructured":"Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, et al. Axonal transport defects in neurodegenerative diseases. J Neurosci J Soc Neurosci. 2009;29:12776\u201386.","journal-title":"J Neurosci J Soc Neurosci"},{"key":"2663_CR27","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0387-7604(02)00103-1","volume":"24","author":"M Hayashi","year":"2002","unstructured":"Hayashi M, Araki S, Arai N, Kumada S, Itoh M, Tamagawa K, et al. Oxidative stress and disturbed glutamate transport in spinal muscular atrophy. Brain Dev. 2002;24:770\u20135.","journal-title":"Brain Dev"},{"key":"2663_CR28","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/jnr.22106","volume":"87","author":"G Acsadi","year":"2009","unstructured":"Acsadi G, Lee I, Li X, Khaidakov M, Pecinova A, Parker GC, et al. Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy. J Neurosci Res. 2009;87:2748\u201356.","journal-title":"J Neurosci Res"},{"key":"2663_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1242\/dmm.021766","volume":"9","author":"CC Xu","year":"2016","unstructured":"Xu CC, Denton KR, Wang ZB, Zhang X, Li XJ. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy. Dis Model Mech. 2016;9:39\u201349.","journal-title":"Dis Model Mech"},{"key":"2663_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.semcdb.2019.07.010","volume":"99","author":"W Guo","year":"2020","unstructured":"Guo W, Stoklund Dittlau K, Van Den Bosch L. Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications. Semin Cell Dev Biol. 2020;99:133\u201350.","journal-title":"Semin Cell Dev Biol"},{"key":"2663_CR31","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1083\/jcb.201904016","volume":"218","author":"L Van Den Bosch","year":"2019","unstructured":"Van Den Bosch L. HDAC6 and Miro1: Another interaction causing trouble in neurons. J Cell Biol. 2019;218:1769\u201370.","journal-title":"J Cell Biol"},{"key":"2663_CR32","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1093\/hmg\/ddx348","volume":"26","author":"A Moller","year":"2017","unstructured":"Moller A, Bauer CS, Cohen RN, Webster CP, De Vos KJ. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels. Hum Mol Genet. 2017;26:4668\u201379.","journal-title":"Hum Mol Genet"},{"key":"2663_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2011.10.018","volume":"147","author":"X Wang","year":"2011","unstructured":"Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell. 2011;147:893\u2013906.","journal-title":"Cell"},{"key":"2663_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.aav9776","volume":"364","author":"S Maniatis","year":"2019","unstructured":"Maniatis S, \u00c4ij\u00f6 T, Vickovic S, Braine C, Kang K, Mollbrink A, et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364:89\u201393.","journal-title":"Science"},{"key":"2663_CR35","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.celrep.2017.01.059","volume":"18","author":"PG Donlin-Asp","year":"2017","unstructured":"Donlin-Asp PG, Fallini C, Campos J, Chou CC, Merritt ME, Phan HC, et al. The Survival of Motor Neuron Protein Acts as a Molecular Chaperone for mRNP Assembly. Cell Rep. 2017;18:1660\u201373.","journal-title":"Cell Rep"},{"key":"2663_CR36","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1093\/hmg\/ddw247","volume":"25","author":"ND Perera","year":"2016","unstructured":"Perera ND, Sheean RK, Crouch PJ, White AR, Horne MK, Turner BJ. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice. Hum Mol Genet. 2016;25:4080\u201393.","journal-title":"Hum Mol Genet"},{"key":"2663_CR37","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.celrep.2017.01.035","volume":"18","author":"N Rodriguez-Muela","year":"2017","unstructured":"Rodriguez-Muela N, Litterman NK, Norabuena EM, Mull JL, Galazo MJ, Sun C, et al. Single-Cell Analysis of SMN Reveals Its Broader Role in Neuromuscular Disease. Cell Rep. 2017;18:1484\u201398.","journal-title":"Cell Rep"},{"key":"2663_CR38","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1093\/hmg\/ddt222","volume":"22","author":"EJN Groen","year":"2013","unstructured":"Groen EJN, Fumoto K, Blokhuis AM, Engelen-Lee J, Zhou Y, van den Heuvel DMA, et al. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum Mol Genet. 2013;22:3690\u2013704.","journal-title":"Hum Mol Genet"},{"key":"2663_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53508-4","volume":"9","author":"R Cacciottolo","year":"2019","unstructured":"Cacciottolo R, Ciantar J, Lanfranco M, Borg RM, Vassallo N, Bordonn\u00e9 R, et al. SMN complex member Gemin3 self-interacts and has a functional relationship with ALS-linked proteins TDP-43, FUS and Sod1. Sci Rep. 2019;9:18666.","journal-title":"Sci Rep"},{"key":"2663_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28:103\u201315.","journal-title":"Neuromuscul Disord"},{"key":"2663_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/hmg\/ddi078","volume":"14","author":"TT Le","year":"2005","unstructured":"Le TT, Pham LT, Butchbach ME, Zhang HL, Monani UR, Coovert DD. et. al. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet. 2005;14:845\u201357.","journal-title":"Hum Mol Genet"},{"key":"2663_CR42","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s42003-023-05543-1","volume":"6","author":"V Valsecchi","year":"2023","unstructured":"Valsecchi V, Errico F, Bassareo V, Marino C, Nuzzo T, Brancaccio P, et al. SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy. Commun Biol. 2023;6:1155.","journal-title":"Commun Biol"},{"key":"2663_CR43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/toxsci\/kfy051","volume":"163","author":"N Guida","year":"2018","unstructured":"Guida N, Valsecchi V, Laudati G, Serani A, Mascolo L, Molinaro P, et al. The miR206-JunD Circuit Mediates the Neurotoxic Effect of Methylmercury in Cortical Neurons. Toxicol Sci J Soc Toxicol. 2018;163:569\u201378.","journal-title":"Toxicol Sci J Soc Toxicol"},{"key":"2663_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105480","volume":"159","author":"S Anzilotti","year":"2021","unstructured":"Anzilotti S, Valsecchi V, Brancaccio P, Guida N, Laudati G, Tedeschi V, et al. Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse model. Neurobiol Dis. 2021;159:105480.","journal-title":"Neurobiol Dis"},{"key":"2663_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00259-020-04842-7","volume":"48","author":"AR Coda","year":"2021","unstructured":"Coda AR, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, et al. In vivo imaging of CNS microglial activation\/macrophage infiltration with combined [18F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis. Eur J Nucl Med Mol Imaging. 2021;48:40\u201352.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2663_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.298","volume":"6","author":"S Anzilotti","year":"2015","unstructured":"Anzilotti S, Tornincasa M, Gerlini R, Conte A, Brancaccio P, Cuomo O, et al. Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype. Cell Death Dis. 2015;6:e2004.","journal-title":"Cell Death Dis"},{"key":"2663_CR47","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.ymthe.2020.01.013","volume":"28","author":"V Valsecchi","year":"2020","unstructured":"Valsecchi V, Anzilotti S, Serani A, Laudati G, Brancaccio P, Guida N, et al. miR-206 Reduces the Severity of Motor Neuron Degeneration in the Facial Nuclei of the Brainstem in a Mouse Model of SMA. Mol Ther J Am Soc Gene Ther. 2020;28:1154\u201366.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"2663_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jneumeth.2012.06.020","volume":"209","author":"BF El-Khodor","year":"2012","unstructured":"El-Khodor BF, Cirillo K, Beltran JA, Mushlin R, Winberg ML, Charney R, et al. Prediction of death in the SMN\u03947 mouse model of spinal muscular atrophy: insight into disease stage and progression. J Neurosci Methods. 2012;209:259\u201368.","journal-title":"J Neurosci Methods"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02663-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02663-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02663-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:37:41Z","timestamp":1759851461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02663-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2663"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02663-x","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. In particular, animal experiments were approved by by the Animal Care Committee of \u201cFederico II\u201d University of Naples, Italy and Ministry of Health, Italy (Authorization N\u00b0 128\/2019; 66\/2024). No human subjects, tissues, or clinical data were involved in this study; therefore, informed consent and consent for publication of human images are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approvals"}}],"article-number":"446"}}